FilingIndex
← The Wire
LIVNNasdaq

LivaNova PLC

Electromedical & Electrotherapeutic Apparatus · X0 · CIK 1639691

LivaNova PLC develops and sells medical devices for cardiopulmonary and neuromodulation applications

$4.36B
Market cap
$83.06
Last close
-0.4%
1D
+5.5%
5D
1.1M
Volume
Price · last 39 sessions+40.6%
May 4L $57.59 · H $83.43Jun 29
252
Total filings
Jun 11, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 11, 202610-Q10-QMay 6, 20268-KResults of OperationsMay 6, 2026DEFA14ADEFA14AApr 29, 2026DEF 14ADEF 14AApr 29, 202610-K10-KFeb 25, 20268-KResults of OperationsFeb 25, 20268-KExecutive ChangeJan 14, 202610-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-KExecutive ChangeSep 4, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KExecutive Change · Shareholder VoteJun 11, 20258-KReg FD DisclosureMay 21, 202510-Q10-QMay 7, 20258-KResults of OperationsMay 7, 2025DEFA14ADEFA14AApr 30, 2025DEF 14ADEF 14AApr 30, 20258-KReg FD DisclosureMar 17, 202510-K10-KFeb 25, 20258-KResults of OperationsFeb 25, 20258-KReg FD DisclosureNov 1, 202410-Q10-QOct 31, 20248-KResults of OperationsOct 30, 20248-KExecutive ChangeOct 8, 20248-KExecutive ChangeSep 10, 202410-Q10-QAug 1, 20248-KResults of OperationsJul 31, 20248-KExecutive Change · Shareholder VoteJun 12, 2024DEFA14ADEFA14AJun 6, 202410-Q10-QMay 3, 20248-KResults of Operations · Reg FD DisclosureMay 1, 2024DEFA14ADEFA14AApr 26, 2024DEF 14AFORM DEF 14AApr 26, 2024SC 13GSC 13GApr 17, 20248-KMaterial Agreement · New Debt / ObligationMar 8, 20248-KReg FD DisclosureMar 6, 20248-KReg FD DisclosureMar 4, 202410-K10-KFeb 29, 20248-KResults of OperationsFeb 21, 20248-KExecutive Change · Company UpdateFeb 5, 20248-KMaterial Impairment · Exit / Disposal CostsJan 8, 20248-KCompany UpdateDec 13, 20238-KCompany UpdateDec 6, 20238-KCompany UpdateNov 20, 202310-Q10-QNov 1, 20238-KResults of OperationsNov 1, 20238-KExecutive ChangeOct 19, 20238-KExecutive ChangeOct 6, 20238-K/AExecutive ChangeSep 21, 20238-KCompany UpdateSep 21, 202310-Q10-QJul 26, 20238-KResults of OperationsJul 26, 20238-KExecutive Change · Shareholder VoteJun 16, 202310-Q10-QMay 3, 20238-KResults of OperationsMay 3, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KExecutive ChangeApr 21, 20238-KExecutive Change · Results of OperationsApr 14, 20238-KReg FD DisclosureMar 24, 202310-K10-KFeb 27, 20238-KExecutive Change · Results of OperationsFeb 22, 20238-KReg FD DisclosureFeb 17, 20238-KReg FD DisclosureJan 19, 20238-KExecutive ChangeDec 14, 20228-KCompany UpdateDec 13, 20228-KReg FD DisclosureNov 28, 20228-KReg FD DisclosureNov 15, 202210-Q10-QNov 2, 20228-KResults of OperationsNov 2, 20228-KReg FD DisclosureOct 11, 20228-KExecutive ChangeSep 15, 20228-KReg FD DisclosureAug 29, 202210-Q10-QAug 3, 20228-KResults of OperationsAug 3, 20228-KMaterial Agreement · Agreement TerminatedJul 6, 20228-KExecutive Change · Shareholder VoteJun 14, 2022DEFA14ALIVANOVA PROXY SUPPLEMENT RE 2022 PLANMay 20, 2022

Insider Activity

In the 90 days to Nov 18, 2025: 1 sold $13K.

DateInsiderActionSharesPriceValue
Nov 18, 2025Story BrookeDirectorSell250$53.94$13K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance